146 related articles for article (PubMed ID: 9039291)
1. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
Han KH; Huh CH; Cho KH
Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
Goette DK; Helwig EB
Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
[TBL] [Abstract][Full Text] [Related]
6. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
Lindboe CF; Løvdal L
Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
[TBL] [Abstract][Full Text] [Related]
7. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
[TBL] [Abstract][Full Text] [Related]
8. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
Stashower ME; Smith K; Corbett D; Skelton HG
J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
Rossen K; Hou-Jensen K; Werdelin O
Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of metallothionein in endometrial lesions.
Ioachim EE; Kitsiou E; Carassavoglou C; Stefanaki S; Agnantis NJ
J Pathol; 2000 Jul; 191(3):269-73. PubMed ID: 10878548
[TBL] [Abstract][Full Text] [Related]
12. Epidermal basaloid proliferation in cutaneous myxomas.
Mehregan DR; Thomas L; Thomas JE
J Cutan Pathol; 2003 Sep; 30(8):499-503. PubMed ID: 12950501
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
15. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
Werynska B; Pula B; Muszczynska-Bernhard B; Piotrowska A; Jethon A; Podhorska-Okolow M; Dziegiel P; Jankowska R
Anticancer Res; 2011 Sep; 31(9):2833-9. PubMed ID: 21868526
[TBL] [Abstract][Full Text] [Related]
16. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
Morgan J; Oseroff AR; Cheney RT
Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.
Kideryová L; Lacina L; Dvoránková B; Stork J; Cada Z; Szabo P; André S; Kaltner H; Gabius HJ; Smetana K
J Dermatol Sci; 2009 Jul; 55(1):18-26. PubMed ID: 19414239
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]